Grove & Mercer is an equity sponsor funded by committed private capital and specializing in middle-market chemical companies. The firm is seeking investments in chemical businesses with EBITDA greater than $5 million and sales exceeding $25 million. Grove & Mercer's investment strategy is the time-honored approach of 'buy, improve, build and hold.' Over time, the firm's objective is to build a $200- to $300-million chemical business. The firm has the capacity to invest up to $20 million in equity in a single transaction.